Neogenomics (NEO) PT Raised to $13 at Piper Sandler
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Price: $16.56 -0.6%
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 19
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 19
Join SI Premium – FREE
Piper Sandler analyst David Westenberg raised the price target on Neogenomics (NASDAQ: NEO) to $13.00 (from $12.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings
- Shanghai Conant Optical (2276:HK) PT Lowered to HK$81.40 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
